WallStreetZenWallStreetZen

NASDAQ: MOTS
Motus Gi Holdings Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for MOTS

Based on 1 analyst offering 12 month price targets for Motus Gi Holdings Inc.
Min Forecast
$11.00+485.11%
Avg Forecast
$11.00+485.11%
Max Forecast
$11.00+485.11%

Should I buy or sell MOTS stock?

Based on 1 analyst offering ratings for Motus Gi Holdings Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MOTS stock forecasts and price targets.

MOTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$11.00+485.11%2022-08-15

1 of 1

Forecast return on equity

Is MOTS forecast to generate an efficient return?
Company
-41.5%
Industry
59.3%
Market
122.06%
MOTS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MOTS forecast to generate an efficient return on assets?
Company
-8.21%
Industry
13.88%
MOTS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MOTS earnings per share forecast

What is MOTS's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$7.50
Avg 2 year Forecast
-$4.10
Avg 3 year Forecast
-$4.74

MOTS revenue forecast

What is MOTS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.1M+138.2%
Avg 2 year Forecast
$3.6M+714.83%
Avg 3 year Forecast
$5.7M+1,171.91%
MOTS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MOTS revenue growth forecast

How is MOTS forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
136.14%
Industry
8.37%
Market
8.53%
MOTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MOTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MOTS vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MOTS$1.88$11.00+485.11%Buy
HTGM$0.56$2.50+343.26%Buy
SQL$0.74$3.00+307.61%Strong Buy
CEMI$0.42N/AN/AHold
OPGN$0.28$3.00+971.43%Buy

Motus Gi Holdings Stock Forecast FAQ

Is Motus Gi Holdings Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MOTS) stock is to Buy MOTS stock.

Out of 1 analyst, 0 (0%) are recommending MOTS as a Strong Buy, 1 (100%) are recommending MOTS as a Buy, 0 (0%) are recommending MOTS as a Hold, 0 (0%) are recommending MOTS as a Sell, and 0 (0%) are recommending MOTS as a Strong Sell.

If you're new to stock investing, here's how to buy Motus Gi Holdings stock.

What is MOTS's earnings growth forecast for 2022-2024?

(NASDAQ: MOTS) Motus Gi Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Motus Gi Holdings's earnings in 2022 is -$19,593,000.On average, 3 Wall Street analysts forecast MOTS's earnings for 2022 to be -$22,476,278, with the lowest MOTS earnings forecast at -$23,405,297, and the highest MOTS earnings forecast at -$20,887,954. On average, 3 Wall Street analysts forecast MOTS's earnings for 2023 to be -$12,287,032, with the lowest MOTS earnings forecast at -$19,719,187, and the highest MOTS earnings forecast at -$5,993,674.

In 2024, MOTS is forecast to generate -$14,205,007 in earnings, with the lowest earnings forecast at -$14,205,007 and the highest earnings forecast at -$14,205,007.

What is MOTS's revenue growth forecast for 2022-2024?

(NASDAQ: MOTS) Motus Gi Holdings's forecast annual revenue growth rate of 136.14% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.37%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Motus Gi Holdings's revenue in 2022 is $445,000.On average, 3 Wall Street analysts forecast MOTS's revenue for 2022 to be $3,176,647, with the lowest MOTS revenue forecast at $2,187,691, and the highest MOTS revenue forecast at $3,895,888. On average, 3 Wall Street analysts forecast MOTS's revenue for 2023 to be $10,866,531, with the lowest MOTS revenue forecast at $6,143,516, and the highest MOTS revenue forecast at $17,981,022.

In 2024, MOTS is forecast to generate $16,962,097 in revenue, with the lowest revenue forecast at $16,962,097 and the highest revenue forecast at $16,962,097.

What is MOTS's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: MOTS) forecast ROA is -8.21%, which is lower than the forecast US Diagnostics & Research industry average of 13.88%.

What is MOTS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MOTS price target, the average MOTS price target is $11.00, with the highest MOTS stock price forecast at $11.00 and the lowest MOTS stock price forecast at $11.00.

The Wall Street analyst predicted that Motus Gi Holdings's share price could reach $11.00 by Aug 15, 2023. The average Motus Gi Holdings stock price prediction forecasts a potential upside of 485.11% from the current MOTS share price of $1.88.

What is MOTS's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: MOTS) Motus Gi Holdings's current Earnings Per Share (EPS) is -$10.26. On average, analysts forecast that MOTS's EPS will be -$7.50 for 2022, with the lowest EPS forecast at -$7.81, and the highest EPS forecast at -$6.97. On average, analysts forecast that MOTS's EPS will be -$4.10 for 2023, with the lowest EPS forecast at -$6.58, and the highest EPS forecast at -$2.00. In 2024, MOTS's EPS is forecast to hit -$4.74 (min: -$4.74, max: -$4.74).

What is MOTS's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: MOTS) forecast ROE is -41.5%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.